Fig. 5: Schematic representation of the winning combination of liquid biopsy analytes to obtain prognostic information in patients with metastatic non-small cell lung cancer (mNSCLC).
PFS Progression-free survival, OS Overall survival.
Fig. 5: Schematic representation of the winning combination of liquid biopsy analytes to obtain prognostic information in patients with metastatic non-small cell lung cancer (mNSCLC). | British Journal of Cancer
